CAPR Capricor Therapeutics, Inc.

Mentions (62)

• Newsnewsfilecorp.com·20h ago·Neutral

  …and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.

  View source ↗
• Newsprnewswire.com·20h ago·Negative

  Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - Hagens Berman SAN FRANCISCO, Aug. 14, 2026 /PRNewswire/ -- Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to submit your losses now . A securities fraud class action lawsuit has been filed against Capricor, and investors are encouraged to contact the firm regarding potential recoveries and lead plaintiff rights.

  View source ↗
• Newsglobenewswire.com·20h ago·Positive

  CAPR Stockholders Have Rights – If You Lost Money Investing in Capricor Therapeutics, Inc. Contact Robbins LLP for Information About Leading the Class Action Robbins LLP is Investigating Allegations That Capricor Therapeutics, Inc. Misled Investors Regarding the Facts About the Path to FDA Approval for Deramioce

  View source ↗
• Newsbusinesswire.com·20h ago·Negative

  Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against Capricor Therapeutics, Inc. (Capricor) (NASDAQ: CAPR) on behalf of those who purchased or acquired Ca…

  View source ↗
• Newsseekingalpha.com·22h ago·Neutral

  …estors Must Know Capricor Therapeutics, Inc. surged 75% after announcing ongoing FDA negotiations for deramiocel, in Duchenne Muscular Dystrophy with cardiomyopathy. CAPR plans to amend its BLA with 24-month HOPE-3 extension data, following positive Lancet publication and FDA willingness to review the new submission. Despite prior AdCom rejection and protocol reporting issues, HOPE-3's primary endpoint may be statistically and clinically significant, supporting potential regulatory reconsiderati…

  View source ↗
• Newsnewsfilecorp.com·22h ago·Neutral

  ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR New York, New York--(Newsfile Corp. - August 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline. SO WHAT…

  View source ↗
• Newsglobenewswire.com·1d ago·Negative

  Kaplan Fox Announces a Securities Class Action Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) – Lead Plaintiff Deadline is September 28, 2026 NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the “Class Period…

  View source ↗
• Newsglobenewswire.com·1d ago·Negative

  CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law LOS ANGELES, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. (“Capricor” or “the Company”) (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities a…

  View source ↗
• Newsglobenewswire.com·1d ago·Negative

  CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit - Contact The Gross Law Firm NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR).

  View source ↗
• Newsbenzinga.com·1d ago·Neutral

  Capricor Therapeutics Remains Optimistic about Deramiocel FDA Approval Capricor Therapeutics Inc. (NASDAQ:CAPR) stock is trading higher on Friday after the gene therapy company released second-quarter earnings on Thursday after market close.

  View source ↗
• Newsnewsfilecorp.com·1d ago·Negative

  Kaplan Fox Encourages Capricor Therapeutics, Inc. (CAPR) Investors with Losses to Contact the Firm Before September 28, 2026 New York, New York--(Newsfile Corp. - August 14, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the "Class Period"). CLICK HERE…

  View source ↗
• Newsreuters.com·1d ago·Neutral

  Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Capricor Therapeutics shares more than doubled in premarket trading on Friday after the company said the U.S. health regulator is willing to review new ​data on its experimental Duchenne muscular dystrophy drug.

  View source ↗
• Newsglobenewswire.com·1d ago·Negative

  CAPR Class Reminder: BFA Law Reminds Capricor Therapeutics Investors of the Upcoming September 28 Deadline in the Securities Fraud Class Action to Recover Losses NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ:CAPR) and certain of the company's senior executives for securities fraud after its significant stock drop resulting from potential violations…

  View source ↗
• Newsprnewswire.com·1d ago·Negative

  CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit NEW YORK, Aug. 13, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.

  View source ↗
• Newsglobenewswire.com·1d ago·Neutral

  ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the “Class Period”), of the important September 28, 2026 lead plaintiff deadline.

  View source ↗
• Newsseekingalpha.com·1d ago·Neutral

  Capricor Therapeutics, Inc. (CAPR) Q2 2026 Earnings Call Prepared Remarks Transcript Capricor Therapeutics, Inc. (CAPR) Q2 2026 Earnings Call Prepared Remarks Transcript

  View source ↗
• Newsmarketbeat.com·1d ago·Negative

  Capricor Therapeutics Q2 Earnings Call Highlights Capricor Therapeutics NASDAQ: CAPR said its biologics license application for deramiocel remains under U.S. Food and Drug Administration review, while the company prepares to submit an amendment seeking a refined indication centered on upper limb skeletal muscle function in Duchenne muscular dystrophy, or DMD.

  View source ↗
• Newsnewsfilecorp.com·1d ago·Negative

  …efore Application Deadline San Francisco, California--(Newsfile Corp. - August 13, 2026) - Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to submit your losses now . A securities fraud class action lawsuit has been filed against Capricor, and investors are encouraged to contact the firm regarding potential recoveries and lead plaintiff rights.

  View source ↗
• Newsnewsfilecorp.com·1d ago·Neutral

  …and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.

  View source ↗
• Newsprnewswire.com·1d ago·Neutral

  CAPR Deadline Alert: SueWallSt Reminds Capricor Therapeutics, Inc. (CAPR) Investors of Securities Class Action Deadline on September 28, 2026 A securities class action alleges Capricor Therapeutics did not follow the pre-specified blinding and protocol procedures for its Phase 3 HOPE-3 trial, with FDA later noting that the final study protocol deviated from the associated statistical analysis plan. NEW YORK, Aug. 13, 2026 /PRNewswire/ -- SueWallSt notifies investors in Capricor Therapeutics, Inc…

  View source ↗
• Newsglobenewswire.com·2d ago·Negative

  CAPR INVESTOR NOTICE: RGRD Law Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Capricor Class Action Lawsuit SAN DIEGO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, all dates inclusive (the “Class Period”), have until September 28, 2026 to seek appointment as lead plaintiff of the C…

  View source ↗
• Newsnewsfilecorp.com·2d ago·Negative

  Kaplan Fox Alerts Investors of Capricor Therapeutics, Inc. (CAPR) to a Pending Securities Class Action - Deadline is September 28, 2026 New York, New York--(Newsfile Corp. - August 13, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the "Class Period").…

  View source ↗
• Newsprnewswire.com·2d ago·Negative

  CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law LOS ANGELES, Aug. 13, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and E…

  View source ↗
• Newsprnewswire.com·2d ago·Neutral

  Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR LOS ANGELES, Aug. 13, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased share…

  View source ↗
• Newsglobenewswire.com·2d ago·Neutral

  …older Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR NEW ORLEANS, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 28, 2026 to file lead plaintiff applications in a securities class action lawsuit against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NasdaqGS: CAPR), if they purcha…

  View source ↗
• Newsglobenewswire.com·2d ago·Negative

  CAPR SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Capricor Therapeutics, Inc. Investors - Contact Kirby McInerney LLP by September 28, 2026 NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Capricor Therapeautics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests i…

  View source ↗
• Newsprnewswire.com·2d ago·Negative

  INVESTOR ALERT: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit SAN DIEGO, Aug. 12, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP  announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), have until September 28, 2026 to seek appointment as lead plaintiff of the Capicor class action lawsu…

  View source ↗
• Newsglobenewswire.com·2d ago·Negative

  CAPRICOR INVESTOR ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. and Encourages Investors to Contact the Firm Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Capricor (CAPR) To Contact Him Directly To Discuss Their Options

  View source ↗
• Newsprnewswire.com·2d ago·Negative

  CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, September 28, 2026 Lead Plaintiff Deadline SAN FRANCISCO, Aug. 12, 2026 /PRNewswire/ -- Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to submit your losses now . A securities fraud class action lawsuit has been filed against Capricor, and investors are encouraged to contact the firm regarding poten

  View source ↗
• Newsglobenewswire.com·3d ago·Negative

  Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm New class action for Capricor (CAPR) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 9/28/2026

  View source ↗
• Newsglobenewswire.com·3d ago·Negative

  Kaplan Fox Alerts Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) with Significant Losses to a Securities Class Action Deadline on September 28, 2026 NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the “Class

  View source ↗
• Newsnewsfilecorp.com·3d ago·Negative

  CAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 29, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson direc

  View source ↗
• Newsprnewswire.com·3d ago·Neutral

  CAPR UPCOMING DEADLINE: Levi & Korsinsky Alerts Capricor Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm Capricor Therapeutics shares collapsed from $19.70 to $4.19 following FDA briefing documents and an adverse advisory committee vote, falling an aggregate 15.08 per share across two corrective-disclosures, or 78.7%, according to allegations in a pending securities class action. NEW YORK, Aug. 12, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in Capri

  View source ↗
• Newsnewsfilecorp.com·3d ago·Negative

  Kaplan Fox Notifies Capricor Therapeutics, Inc. (CAPR) Investors of a Securities Class Action Deadline on September 28, 2026 New York, New York--(Newsfile Corp. - August 12, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the "Class Period"). CLICK HERE

  View source ↗
• Newsglobenewswire.com·3d ago·Negative

  CAPR Securities Lawsuit: Capricor Therapeutics Securities Fraud Class Action is Pending – Contact BFA Law before September 28 if You Lost Money after the 64% Stock Drop NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ:CAPR) and certain of the company's senior executives for securities fraud after its significant stock drop resulting from potential vi

  View source ↗
• Newsglobenewswire.com·3d ago·Neutral

  Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline NEW YORK and NEW ORLEANS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NasdaqGS: CAPR) of a class action securities lawsuit.

  View source ↗
• Newsglobenewswire.com·3d ago·Negative

  Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline SAN FRANCISCO, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to submit your losses now . A securities fraud class action lawsuit has been filed against Capricor, and investors are encouraged to contact the fir

  View source ↗
• Newsbusinesswire.com·3d ago·Negative

  CAPR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit SAN DIEGO--(BUSINESS WIRE)---- $CAPR #CAPR--The case alleges Capricor Therapeutics and certain of its top executives made false and/or misleading statements to investors.

  View source ↗
• Newsglobenewswire.com·3d ago·Neutral

  INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980.

  View source ↗
• Newsnewsfilecorp.com·3d ago·Neutral

  ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR New York, New York--(Newsfile Corp. - August 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline. SO WHAT: If

  View source ↗
• Newsnewsfilecorp.com·3d ago·Negative

  CAPR INVESTOR ALERT: Capricor Therapeutics Securities Class Action Filed; September 28, 2026 Lead Plaintiff Deadline - Kehoe Law Firm Philadelphia, Pennsylvania--(Newsfile Corp. - August 11, 2026) - Kehoe Law Firm, P.C. announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, both dates inclusive (the "C

  View source ↗
• Newsprnewswire.com·4d ago·Negative

  CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit - Contact The Gross Law Firm NEW YORK, Aug. 11, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

  View source ↗
• Newsnewsfilecorp.com·4d ago·Negative

  Kaplan Fox Reminds Capricor Therapeutics, Inc. (CAPR) Investors Seeking Recovery of the Lead Plaintiff Deadline on September 28, 2026 New York, New York--(Newsfile Corp. - August 11, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the "Class Period"). C

  View source ↗
• Newsprnewswire.com·4d ago·Negative

  CAPR Investor Announcement: Capricor Therapeutics Sued on behalf of Investors to Recover Losses after Clinical Data Leads to 64% Stock Drop Capricor Therapeutics, Inc. has been sued for securities fraud over alleged misstatements about Deramiocel and the integrity of the clinical data supporting its Biologics License Application leading to a 64% stock drop. NEW YORK, Aug. 11, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP  announces that a class action lawsuit has be

  View source ↗
• Newsprnewswire.com·4d ago·Negative

  CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit SAN FRANCISCO, Aug. 11, 2026 /PRNewswire/ -- Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to submit your losses now . A securities fraud class action lawsuit has been filed against Capricor, and investors are encouraged to contact the firm regarding potential recoveries and lead plaintif

  View source ↗
• Newsnewsfilecorp.com·4d ago·Neutral

  Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 10, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities

  View source ↗
• Newsnewsfilecorp.com·5d ago·Neutral

  Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm New York, New York--(Newsfile Corp. - August 10, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ: CAPR) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal s

  View source ↗
• Newsglobenewswire.com·5d ago·Negative

  Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Who Suffered Losses to a Securities Class Action – Deadline is September 28, 2026 NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the “Class Perio

  View source ↗
• Newsnewsfilecorp.com·5d ago·Negative

  CAPR EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 29, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson di

  View source ↗
• Newsglobenewswire.com·5d ago·Neutral

  Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13 – Company to Host Conference Call on August 13, 2026, at 4:30 p.m. ET – – Company to Host Conference Call on August 13, 2026, at 4:30 p.m. ET –

  View source ↗
• Newsprnewswire.com·5d ago·Neutral

  Berger Montague PC Investigating Claims on Behalf of Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors After Class Action Filing PHILADELPHIA, Aug. 10, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) ("Capricor" or the "Company") on behalf of investors who purchased or acquired Capricor securities during the period from December 17, 2025 through July 26, 2026 (the "Class Period"). Investo

  View source ↗
• Newsprnewswire.com·5d ago·Negative

  CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, September 28, 2026 Lead Plaintiff Deadline SAN FRANCISCO, Aug. 10, 2026 /PRNewswire/ -- Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR)  who suffered substantial losses to submit your losses now . A securities fraud class action lawsuit has been filed against Capricor, and investors are encouraged to contact the firm regarding pote

  View source ↗
• Newsnewsfilecorp.com·5d ago·Negative

  Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (CAPR) Investors to a Securities Class Action Deadline on September 28, 2026 New York, New York--(Newsfile Corp. - August 10, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ: CAPR) ("Capricor" or the "Company") on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the "Class Perio

  View source ↗
• Newsglobenewswire.com·5d ago·Neutral

  Capricor Therapeutics (NASDAQ:CAPR) Securities Class Action Notice: Investors who Lost Money when Stock Plummeted 64% are Notified to Contact BFA Law by September 28 Capricor Therapeutics Securities Class Action Notice: Investors who Lost Money when Stock Plummeted 64% are Notified to Contact BFA Law by September 28

  View source ↗
• Newsprnewswire.com·5d ago·Neutral

  Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR LOS ANGELES, Aug. 10, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased share

  View source ↗
• Newsgurufocus.com·5d ago·Negative

  CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law PR Newswire

  View source ↗
• Newsprnewswire.com·5d ago·Negative

  CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law LOS ANGELES, Aug. 10, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and E

  View source ↗
• Newsglobenewswire.com·6d ago·Neutral

  Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm NEW YORK, Aug. 09, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ: CAPR) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities law

  View source ↗
• Newsnewsfilecorp.com·6d ago·Neutral

  ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR New York, New York--(Newsfile Corp. - August 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"). A class action lawsuit has already

  View source ↗
• Newsprnewswire.com·6d ago·Negative

  CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit NEW YORK, Aug. 8, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.

  View source ↗
• Newsgurufocus.com·7d ago·Neutral

  Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Act

  View source ↗
• Newsprnewswire.com·7d ago·Neutral

  Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR /PRNewswire/ -- - ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 28, 2026 to file lead plaintiff

  View source ↗